Viewing Study NCT04665895


Ignite Creation Date: 2025-12-24 @ 1:32 PM
Ignite Modification Date: 2025-12-28 @ 1:58 AM
Study NCT ID: NCT04665895
Status: COMPLETED
Last Update Posted: 2023-04-06
First Post: 2020-12-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUSĀ® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma
Sponsor: Respirent Pharmaceuticals Co Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module